Page 18 - Read Online
P. 18

[22]
         evaluated by USgFNAC and the patients were stratified for   Vijayakumar et al.  found that about 50% of patients with
         T-staging classification. Observation of the neck consisted of   tongue tumor depth more than 4 mm had grade III and IV
         ultrasonographic examination every 3 months during the first   tumors. The incidence of occult metastasis was 62.2%, which
         3-year follow-up, which strongly resembles our wait and scan   is  significantly  higher  than  for  other  subsites  of  the  oral
         follow-up policy. Although the sample size was limited, this   cavity. Thirty eight (33.9%) patients with occult metastasis
         study had the preferable study design to compare the outcome   had ECS, which is a poor prognostic feature. Another poor
         of elective neck treatment with observation. The reported 5-year   prognostic indicator they detected was multiple levels of
         disease-specific  survival  rates  were  not  significantly  different   nodal involvement in 79 (70.5%) patients. As expected most
         (observation arm 87%, END arm 89%). [14]            of the lymph nodes were localized to levels I, II and III. But
                                                             level IV was involved in 23 patients. [22]
         In the study of Feng et al.  total regional recurrence rate of the
                            [16]
                                                                                     [13]
         untreated N0 neck was found to be 19.2% for stage T1 (8/48,   In  the study of Huang  et al.  neck  recurrence  rate in the
         16.7%) and stage T2 (6/25, 24.0%), respectively. 92.9% of them   OBS  group  (28.6%)  was  significantly  higher  compared  with
         occurred in the early postoperative period (within 2 years). Of these   that observed in the END group (12.7%, P = 5.004). Although
         regional recurrences, only 41.7% patients were successful salvaged due   contralateral  regional  metastases  have  been  described  in
         to advanced neck disease. In their department, observation policy for   some series of patients with early stage tumors of the oral
         clinically N0 neck was more common in patients with the stage T1   cavity, [26,66]  their data show that neck recurrence is mainly
         tumours, so that the T1/T2 ratio for the randomized controlled study   ipsilateral in patients treated with glossectomy alone. Among
         was unbalanced (T1/T2 ratio in “END vs. observation”: 0.6 vs. 1.9).   patients treated with END, 12.7% developed a regional
         Although the patients from the observation group had a higher   recurrence. Contralateral level I lymph nodes were the most
         proportion of stage T1, They found that the patients from END group   frequent site of regional recurrence. This finding was in line
                                                                             [66]
         exhibited significantly better DSS rates than those from observation   with previous data.  It is posited that this phenomenon may
         group. They further analysed the prognosis of subgroups (T1/T2)   be due to an afferent communicating pathway that drains from
                                                                                                             [67]
         in each group, the results showed that the patients from the END   the floor of the mouth into the contralateral lymph nodes.
         group with stage T2 tumours had a higher survival rate than those   This may also occur silently before surgery. The second most
         from the observation group. [16]                    common site of regional recurrence was ipsilateral level I
                                                             nodes. In their study, the 5-year cervical control rates was
                                                             much better for patients treated by END compared with OBS.
         Weiss et al.  suggested that END is necessary if the incidence of
                 [3]
         occult metastasis is greater than 20%. The proponents of wait   In addition, the 5-year OS in the END group was superior
         and watch policy argue that 80% of patients with N0 neck would   compared with patients who had a subsequent therapeutic
         be over treated, and subjected to additional morbidity and costs.   neck dissection. These data are in line with previous studies
                                                             in early-stage tongue cancer.  It is thus posited that END
                                                                                     [65]
         Though this argument may apply to most oral cavity tumors, the   might improve both neck control and OS. Indeed, application
         cancer of the tongue must be viewed as a separate entity. The   of  this  technique  might  improve  the  chance  of  clearance
         incidence of nodal metastasis is higher for early cancer of the   of micrometastasis that cannot be detected by histology
         tongue when compared with other sites of the oral cavity. [62,63]    or imaging. However, their data provide evidence that, in
         D’Cruz et al.  found the incidence of nodal metastasis to be   the group of patients treated by END, the incidence of skip
                   [15]
         37.5% in T1 lesions and 62.5% in T2 lesions of the oral tongue.   metastasis to level IV in the absence of level I/II lesions is as
         Andersen et al.  studied the results of neck failure following   low as 2.7% (1 case out of 37 patients). In the OBS group,
                     [64]
         observation of N0 necks. They found that 60% of patients had   the skip metastasis rate was 5.4% (3 of 56) in patients with
         N2 disease and 49% had extracapsular spread (ECS). Either or   regional recurrence who  received  salvage neck dissection.
         both these adverse prognostic factors were present at the time   In their report the skip metastatic rate was lower compared
         of surgery in 77% of patients. [22,62-64]           with that reported in previous studies. [68-71]  However, in their
                                                             study all patients were staged with the use of CT/MR imaging.
         Four RCTs have been performed to compare END with wait   In the light of our data, routine dissection of level IV lymph
         and watch policy. Two of the trials were conducted purely on   node alongside supraomohyoid neck dissection can provide
         early oral tongue cancers. Fakih et al.  in a series on T1 and   little benefit to patients with early-stage tongue cancer.
                                       [65]
         T2 lesions, compared END with observation. They found that   It is concluded that level IV nodes should not be routinely
         there was no survival difference between the two groups. They   included in the neck dissection for patients with negative
         found that a tumor depth of more than 4 mm was associated   neck as assessed by CT/MRI scans.
         with higher rates of involved nodes and suggested that these
         set of patients may benefit from END. A more recent RCT from   In the study of Dias et al.  analyzing the two groups of patients
                                                                                [6]
         Hong Kong compared END versus observation for T1 and T2   (resection of the primary tumor alone-RA and resection of
         lesions of the oral tongue. The authors had a robust follow-  the primary tumor "plus" elective neck disection-XR+END)
         up protocol of clinical and ultrasonographic examination of   according to the incidence of regional recurrence, they
         the neck to detect recurrences. They were able to salvage all   found a 24% incidence in the RA group compared with a 4%
         neck recurrences in the observational arm and thus found no   incidence in the R+END group. The 20% difference between the
         survival differences between the two arms.  All the above   two groups was statistically significant (P = 0.03). Differences
                                             [14]
         RCTs had small numbers and consisted of methodology flaws   between disease-free survival of 97% for the R+END group and
         making their conclusions difficult to inculcate into clinical   of 74% for the RA group were also statistically significant (P =
                                                                                                           [34]
         practice.                                           0.05). These findings confirm the results of Kligerman et al.  in
         170                                                                     Plast Aesthet Res || Volume 3 || May 25, 2016
   13   14   15   16   17   18   19   20   21   22   23